Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q3 2015 · 10-Q
Revenue—
Net Income-$4.03M-$4.03MN/M vs Q3 2014 EPS Diluted-$0.02-$0.02N/M vs Q3 2014 Operating Income-$4,658,555N/M Operating Cash Flowderived-$4,502,473N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 2, 2015 · 33 d after period end